Brussels, 16 Ocotober 2012: EFPIA is committed to building trust in how the pharmaceutical industry conducts its business and interacts with key stakeholders. For that reason we have strongly supported Commissioner Tajani’s initiative on Corporate Social Responsibility in the pharmaceutical sector, with its emphasis on the industry’s relationships with its key stakeholders. One of the most important relationships that the industry has is with healthcare professionals (HCPs).
Code of conduct
Paris, 12-16 November 2012
Leaders of industry have asked that EFPIA coordinate monitoring of European events, by setting up an on-line platform including pre-assessment reports of events sponsored by industry and attended by healthcare professionals (HCP) in regard of EFPIA’s HCP Code, in particular in regard of Article 9 provisions of this Code on “events & hospitality”. Reports posted on the EFPIA e4ethics website will be shared with corporate compliance officers, the national ethics groups, and congress and meeting organisers to promote compliance with industry standards.
The amended code requires companies to disclose the monetary value of financial support and of invoiced costs (art. 5), includes a new article on 'contracted sevices' (art. 6) and amends art. 8 (events and hospitality).
14 June 2011, EFPIA's General Assembly has approved the amended Code of Practice on the promotion of prescription-only medicines to, and interactions with, healthcare professionals.
The amended code is effective from 1 January 2012.
The objective of the Codes of Practice is to ensure the highest possible standards in the promotion and advertising of medicines.
EFPIA Code of Practice on the promotion of prescription-only medicines to, and interactions with, healthcare professionals (Amended following Statutory General Assembly approval of 14 June 2011)